Literature DB >> 23745314

Combination of intra-articular autologous activated peripheral blood stem cells with growth factor addition/ preservation and hyaluronic acid in conjunction with arthroscopic microdrilling mesenchymal cell stimulation Improves quality of life and regenerates articular cartilage in early osteoarthritic knee disease.

Thana Turajane1, Ukrit Chaweewannakorn, Viroj Larbpaiboonpong, Jongjate Aojanepong, Thakoon Thitiset, Sittisak Honsawek, Juthatip Fongsarun, Konstantinos I Papadopoulos.   

Abstract

BACKGROUND: Trauma or osteoarthritis (OA) create articular cartilage defects that cannot efficiently heal, thus leading to significant long-term disability. Failed conservative treatment in cartilage diseases is a known condition that necessitates repair attempts but current methods are inadequate. Recent studies in OA animal models and humans, showed articular cartilage regeneration following combinations of drilling, adult stem cells, and intra-articular hyaluronic acid.
OBJECTIVE: In the present series, the authors evaluated the combination of repeated intra-articular (IA) autologous activated peripheral blood stem cells (AAPBSC) with growth factor addition/preservation (GFAP) along with hyaluronic acid (HA) in conjunction with arthroscopic microdrilling mesenchymal cell stimulation (MCS) in early osteoarthritic knee disease that failed conservative treatment. MATERIAL AND
METHOD: Four women and one man (median age 56, range 52-59 years) that failed conservative treatment were enrolled. Arthroscopic MCS was performed once in all patients with subsequent IA injection of AAPBSC with GFAP along with IA-HA intra-operatively, repeated at days 7 and 14. The patients were evaluated by WOMAC and KOO scores at baseline, one, and six months. Cancellous bone biopsies were performed to investigate cell attachment, proliferation, and differentiation by electron microscopy and histological staining.
RESULTS: All patients improved significantly in WOMAC and KOO scores at one and six months compared to baseline. No adverse effects were seen during the AAPBSC harvesting, arthroscopy and/or IA injections. One month post-surgery, all pain medications could be withdrawn. Electron microscopy scanning revealed cell attachment and proliferation while histological analysis demonstrated that the cell layer on the cancellous scaffold showed increased proteoglycan and glycosaminoglycan content indicating hyaline cartilage presence.
CONCLUSION: The combination of intra-articular (IA) autologous activated peripheral blood stem cells (AAPBSC) with growth factor addition/preservation (GFAP) along with hyaluronic acid (HA) in conjunction with arthroscopic microdrilling mesenchymal cell stimulation (MCS) resulted in Quality of Life improvements measured by WOMAC and KOO scores and succeeded in regenerating articular cartilage in early osteoarthritic knee disease that failed conservative treatment. Further controlled studies are warranted to confirm the above results in larger groups.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23745314

Source DB:  PubMed          Journal:  J Med Assoc Thai        ISSN: 0125-2208


  19 in total

1.  Cartilage repair techniques in the knee: stem cell therapies.

Authors:  Shinichi Yoshiya; Aman Dhawan
Journal:  Curr Rev Musculoskelet Med       Date:  2015-12

2.  Assessment of chondrogenic differentiation potential of autologous activated peripheral blood stem cells on human early osteoarthritic cancellous tibial bone scaffold.

Authors:  T Turajane; T Thitiset; S Honsawek; U Chaveewanakorn; J Aojanepong; K I Papadopoulos
Journal:  Musculoskelet Surg       Date:  2013-11-01

Review 3.  Repair and tissue engineering techniques for articular cartilage.

Authors:  Eleftherios A Makris; Andreas H Gomoll; Konstantinos N Malizos; Jerry C Hu; Kyriacos A Athanasiou
Journal:  Nat Rev Rheumatol       Date:  2014-09-23       Impact factor: 20.543

Review 4.  Mesenchymal stem cells injections for knee osteoarthritis: a systematic overview.

Authors:  Dan Xing; Qi Wang; Ziyi Yang; Yunfei Hou; Wei Zhang; Yaolong Chen; Jianhao Lin
Journal:  Rheumatol Int       Date:  2017-12-22       Impact factor: 2.631

5.  Efficacy of mesenchymal stem cells in treating patients with osteoarthritis of the knee: A meta-analysis.

Authors:  Gang-Hua Cui; Yang Yang Wang; Chang-Jun Li; Chen-Hui Shi; Wei-Shan Wang
Journal:  Exp Ther Med       Date:  2016-10-11       Impact factor: 2.447

6.  Novel Use of Intraarticular Granulocyte Colony Stimulating Factor (hG-CSF) Combined with Activated Autologous Peripheral Blood Stem Cells Mobilized with Systemic hG-CSF: Safe and Efficient in Early Osteoarthritis.

Authors:  Konstantinos I Papadopoulos; Mantana Paisan; Warachaya Sutheesophon; Thana Turajane
Journal:  Cartilage       Date:  2021-10-12       Impact factor: 3.117

7.  Cell therapy in joint disorders.

Authors:  Peter D Counsel; Daniel Bates; Richard Boyd; David A Connell
Journal:  Sports Health       Date:  2015-01       Impact factor: 3.843

8.  Peripheral Blood Mononuclear Cells Enhance Cartilage Repair in in vivo Osteochondral Defect Model.

Authors:  Niina Hopper; John Wardale; Roger Brooks; Jonathan Power; Neil Rushton; Frances Henson
Journal:  PLoS One       Date:  2015-08-07       Impact factor: 3.240

9.  Combined use of the Ilizarov method, concentrated bone marrow aspirate (cBMA), and platelet-rich plasma (PRP) to expedite healing of bimalleolar fractures.

Authors:  Edgardo R Rodriguez-Collazo; Maria L Urso
Journal:  Strategies Trauma Limb Reconstr       Date:  2015-11-24

Review 10.  Stem cells in articular cartilage regeneration.

Authors:  Giuseppe Filardo; Francesco Perdisa; Alice Roffi; Maurilio Marcacci; Elizaveta Kon
Journal:  J Orthop Surg Res       Date:  2016-04-12       Impact factor: 2.359

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.